Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
Clinical trial NCT02980133 · COMPLETED
Trial details
- NCT number
- NCT02980133
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-28
- Primary completion
- 2019-04-07
- Enrollment
- 841
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.